811 related articles for article (PubMed ID: 35271839)
1. Reduced dopaminergic neuron degeneration and global transcriptional changes in Parkinson's disease mouse brains engrafted with human neural stems during the early disease stage.
Pereira MCL; Boese AC; Murad R; Yin J; Hamblin MH; Lee JP
Exp Neurol; 2022 Jun; 352():114042. PubMed ID: 35271839
[TBL] [Abstract][Full Text] [Related]
2. Molecular Regulatory Mechanism and Toxicology of Neurodegenerative Processes in MPTP/Probenecid-Induced Progressive Parkinson's Disease Mice Model Revealed by Transcriptome.
Yang W; Hao W; Meng Z; Ding S; Li X; Zhang T; Huang W; Xu L; Zhang Y; Yang J; Gu X
Mol Neurobiol; 2021 Feb; 58(2):603-616. PubMed ID: 32997292
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
Pariyar R; Bastola T; Lee DH; Seo J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
[TBL] [Abstract][Full Text] [Related]
4. Brain Selective Estrogen Treatment Protects Dopaminergic Neurons and Preserves Behavioral Function in MPTP-induced Mouse Model of Parkinson's Disease.
Thadathil N; Xiao J; Hori R; Alway SE; Khan MM
J Neuroimmune Pharmacol; 2021 Sep; 16(3):667-678. PubMed ID: 33221984
[TBL] [Abstract][Full Text] [Related]
5. miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson's disease.
Hu YB; Zhang YF; Wang H; Ren RJ; Cui HL; Huang WY; Cheng Q; Chen HZ; Wang G
Cell Death Dis; 2019 Aug; 10(8):589. PubMed ID: 31383850
[TBL] [Abstract][Full Text] [Related]
6. Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease.
Pak ME; Ahn SM; Jung DH; Lee HJ; Ha KT; Shin HK; Choi BT
J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):712-721. PubMed ID: 31644786
[TBL] [Abstract][Full Text] [Related]
7. The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease.
Prediger RD; Aguiar AS; Moreira EL; Matheus FC; Castro AA; Walz R; De Bem AF; Latini A; Tasca CI; Farina M; Raisman-Vozari R
Curr Pharm Des; 2011; 17(5):489-507. PubMed ID: 21375482
[TBL] [Abstract][Full Text] [Related]
8. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease.
Pupyshev AB; Tikhonova MA; Akopyan AA; Tenditnik MV; Dubrovina NI; Korolenko TA
Pharmacol Biochem Behav; 2019 Feb; 177():1-11. PubMed ID: 30582934
[TBL] [Abstract][Full Text] [Related]
11. NRF1 mitigates motor dysfunction and dopamine neuron degeneration in mice with Parkinson's disease by promoting GLRX m
Gong X; Huang M; Chen L
CNS Neurosci Ther; 2024 Mar; 30(3):e14441. PubMed ID: 37735974
[TBL] [Abstract][Full Text] [Related]
12. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
13. Analysis of m6A modification regulators in the substantia nigra and striatum of MPTP-induced Parkinson's disease mice.
Yu Z; Huang L; Xia Y; Cheng S; Yang C; Chen C; Zou Z; Wang X; Tian X; Jiang X; Zhou L
Neurosci Lett; 2022 Nov; 791():136907. PubMed ID: 36209975
[TBL] [Abstract][Full Text] [Related]
14. Modulation of gene expression on a transcriptome-wide level following human neural stem cell transplantation in aged mouse stroke brains.
Hamblin MH; Murad R; Yin J; Vallim G; Lee JP
Exp Neurol; 2022 Jan; 347():113913. PubMed ID: 34752785
[TBL] [Abstract][Full Text] [Related]
15. 1-Methyl-4-phenyl-1,2,3,6 tetrahydropyridine/probenecid impairs intestinal motility and olfaction in the early stages of Parkinson's disease in mice.
Choi JG; Huh E; Ju IG; Kim N; Yun J; Oh MS
J Neurol Sci; 2018 Sep; 392():77-82. PubMed ID: 30031172
[TBL] [Abstract][Full Text] [Related]
16. Whole-Transcriptome Analysis of Mouse Models with MPTP-Induced Early Stages of Parkinson's Disease Reveals Stage-Specific Response of Transcriptome and a Possible Role of Myelin-Linked Genes in Neurodegeneration.
Alieva AK; Zyrin VS; Rudenok MM; Kolacheva AA; Shulskaya MV; Ugryumov MV; Slominsky PA; Shadrina MI
Mol Neurobiol; 2018 Sep; 55(9):7229-7241. PubMed ID: 29397556
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Potential of Repeated Intravenous Transplantation of Human Adipose-Derived Stem Cells in Subchronic MPTP-Induced Parkinson's Disease Mouse Model.
Park H; Chang KA
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143234
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of osmotin in Parkinson's disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways.
Park JS; Choe K; Lee HJ; Park TJ; Kim MO
J Biomed Sci; 2023 Aug; 30(1):66. PubMed ID: 37568205
[TBL] [Abstract][Full Text] [Related]
19. MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling.
Fujita A; Fujita Y; Pu Y; Chang L; Hashimoto K
Psychopharmacology (Berl); 2020 Jan; 237(1):83-92. PubMed ID: 31418048
[TBL] [Abstract][Full Text] [Related]
20. Zinc Deficiency Exacerbates Behavioral Impediments and Dopaminergic Neuron Degeneration in a Mouse Model of Parkinson Disease.
Zhang X; Wang K; Ren XL; Zhang MD; Wu KN; Wu H; Chu ZW; Liu SS; Jiang XX; Zhu JH; Wu HM
J Nutr; 2023 Jan; 153(1):167-175. PubMed ID: 36913450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
